Bio-Medicine
Bio-Medicine
Partnering with Mabwell to Advance Biopharmaceutical Innovation in Egypt
Advocure is committed to bringing cutting-edge therapies from R&D to patients in Egypt.
Details
Details
Details
Mabwell has established an advanced R&D system which covers target discovery, early discovery, druggability, preclinical, clinical research and manufacturing transformation.
The international standard drug discovery platforms and skillful & efficient development platforms enables the development of innovative biologics efficiently and submiting IND rapidly. Focusing on large-scale, fast-growing therapeutic areas including oncology, immunology, bone disorders, ophthalmology, hematology and infectious diseases, etc. Mabwell has 16 pipeline products. Of these, 4 products have been approved and commercialized, 1 product filed for pre-NDA meeting, 2 products are in pivotal trials. Also undertaken 1 national major scientific and technological special project for "Significant New Drugs Development", 2 projects for National Key R&D Programmes, and multiple provincial and municipal science and technological innovation projects.
Mabwell has established an advanced R&D system which covers target discovery, early discovery, druggability, preclinical, clinical research and manufacturing transformation.
The international standard drug discovery platforms and skillful & efficient development platforms enables the development of innovative biologics efficiently and submiting IND rapidly. Focusing on large-scale, fast-growing therapeutic areas including oncology, immunology, bone disorders, ophthalmology, hematology and infectious diseases, etc. Mabwell has 16 pipeline products. Of these, 4 products have been approved and commercialized, 1 product filed for pre-NDA meeting, 2 products are in pivotal trials. Also undertaken 1 national major scientific and technological special project for "Significant New Drugs Development", 2 projects for National Key R&D Programmes, and multiple provincial and municipal science and technological innovation projects.
Mabwell has established an advanced R&D system which covers target discovery, early discovery, druggability, preclinical, clinical research and manufacturing transformation.
The international standard drug discovery platforms and skillful & efficient development platforms enables the development of innovative biologics efficiently and submiting IND rapidly. Focusing on large-scale, fast-growing therapeutic areas including oncology, immunology, bone disorders, ophthalmology, hematology and infectious diseases, etc. Mabwell has 16 pipeline products. Of these, 4 products have been approved and commercialized, 1 product filed for pre-NDA meeting, 2 products are in pivotal trials. Also undertaken 1 national major scientific and technological special project for "Significant New Drugs Development", 2 projects for National Key R&D Programmes, and multiple provincial and municipal science and technological innovation projects.
Have Additional Questions?
Have Additional Questions?
Have Additional Questions?
